Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) EVP Mark Brosius sold 46 shares of the firm’s stock in a transaction that occurred on Monday, November 16th. The shares were sold at an average price of $444.38, for a total value of $20,441.48. Following the completion of the transaction, the executive vice president directly owned 411 shares of the company’s stock, valued at $182,640.18. The trade was a 10.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Mark Brosius also recently made the following trade(s):
- On Wednesday, November 18th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The stock was sold at an average price of $430.63, for a total value of $19,808.98.
- On Wednesday, October 28th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The stock was sold at an average price of $441.60, for a total value of $26,937.60.
- On Monday, October 26th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The shares were sold at an average price of $451.75, for a total value of $27,556.75.
- On Friday, September 11th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The shares were sold at an average price of $365.79, for a total value of $9,144.75.
- On Wednesday, September 9th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $350.20, for a total transaction of $8,054.60.
- On Tuesday, September 8th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The shares were sold at an average price of $361.23, for a total transaction of $16,616.58.
- On Friday, August 21st, Mark Brosius sold 77 shares of Intuitive Surgical stock. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89.
Intuitive Surgical Stock Down 2.2%
Shares of ISRG traded down $9.58 during mid-day trading on Wednesday, reaching $420.95. 2,213,548 shares of the company’s stock were exchanged, compared to its average volume of 2,435,968. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The company has a market cap of $145.92 billion, a price-to-earnings ratio of 50.90, a PEG ratio of 3.02 and a beta of 1.45. The company has a 50-day simple moving average of $421.98 and a two-hundred day simple moving average of $428.75.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. Intuitive Surgical’s revenue was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.40 EPS. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on ISRG shares. BTIG Research raised their price target on shares of Intuitive Surgical from $454.00 to $513.00 and gave the stock a “buy” rating in a research note on Wednesday. Mizuho reduced their price objective on shares of Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 21st. Raymond James Financial restated an “outperform” rating and set a $480.00 target price on shares of Intuitive Surgical in a research report on Wednesday, October 21st. UBS Group reaffirmed a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, October 13th. Finally, BNP Paribas Exane upgraded Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. One analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $495.90.
Check Out Our Latest Analysis on Intuitive Surgical
Recent Intuitive Surgical Headlines
Investors following ISRG have been watching these headlines:
- Positive Sentiment: BTIG Research raised its price target to $513 from $454 and reiterated a “buy” rating, implying substantial upside from the reference price. BTIG Research ratings
- Positive Sentiment: A recent earnings-focused report highlighted 25% adjusted EPS growth to $3, supported by broader robotic-platform adoption and AI-related innovation. Revenue growth has also been strong. ISRG EPS climbs 25%
- Neutral Sentiment: Another analysis argues ISRG may be near fair value despite revenue growth, focusing on whether future cash flows justify its valuation as competition increases and new robotic platforms enter the market. This valuation debate could limit enthusiasm for the shares. ISRG stock may be near fair value
Hedge Funds Weigh In On Intuitive Surgical
Large investors have recently bought and sold shares of the stock. Fairscale Capital LLC grew its holdings in shares of Intuitive Surgical by 3.5% during the third quarter. Fairscale Capital LLC now owns 645 shares of the medical equipment provider’s stock worth $279,000 after purchasing an additional 22 shares in the last quarter. Beaumont Financial Advisors LLC raised its stake in Intuitive Surgical by 3.8% in the third quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock valued at $255,000 after purchasing an additional 23 shares in the last quarter. Hughes Financial Services LLC lifted its position in Intuitive Surgical by 40.7% during the third quarter. Hughes Financial Services LLC now owns 83 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 24 shares during the last quarter. Blue Fin Capital Inc. grew its position in Intuitive Surgical by 0.5% in the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock worth $2,210,000 after acquiring an additional 25 shares in the last quarter. Finally, Red Spruce Capital LLC grew its position in Intuitive Surgical by 4.1% in the second quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider’s stock worth $255,000 after acquiring an additional 25 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Further Reading
- Five stocks we like better than Intuitive Surgical
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
